The top-tier life sciences company will standardize its Safety operations on the cloud-powered technology platform, LifeSphere, which is propelling life sciences GenAI use cases.
Nuckols will apply decades of both life sciences and technology leadership to enhance innovation and customer focus at ArisGlobal
The international survey reveals that there is currently a pronounced gap between Life Sciences organizations’ intentions and their actual use of next-generation technologies.
LifeSphere Clarity drives efficiencies and reinvents the way Boehringer Ingelheim’s ...
Advanced Intake™ demonstrates up to 65% efficiency gains in adverse ...
Following a successful inaugural gathering in the USA in February, leading global pharmaceutical organizations & AI specialists will meet in Switzerland on May 15th to further fuel adoption of next-generation technologies transforming Life Sciences R&D.
Launched at Breakthrough 2024, ArisGlobal announced Advanced Intake, Real-World Data Subscription, & its Next-Generation LifeSphere Regulatory Platform LONDON, UK – March 20, 2024 – ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, today announced three cutting-edge product offerings that will transform pharmacovigilance and regulatory operations.
Drug Safety teams across the globe now have access to ...
30 executive speakers and more than 200 expected attendees will ...
Sitero, the next-generation clinical trial solutions provider and specialist in ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved